Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
Sponsor: AstraZeneca
Summary
The CHOROS pooled analysis is a retrospective secondary data use analysis of integrated individual participant data from a series of planned and on-going primary prospective, non-interventional, multi-center studies sponsored by AstraZeneca and conducted in the pulmonary/primary care practitioner setting in multiple countries and may include data from the following countries: United Kingdom, Germany, Italy, Greece, Japan, Canada and Romania.
Official title: Pooled Analysis of Multi-country, Open-label Single-arm, Non-interventional, Multi-center, Cohort Studies of Real-world Outcomes in New Users of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2025-04-17
Completion Date
2026-12-14
Last Updated
2026-03-24
Healthy Volunteers
No
Conditions
Interventions
Budesonide/glycopyrrolate/formoterol fumarate
Budesonide/glycopyrrolate/formoterol fumarate (BGF) is a triple fixed-dose combination therapy for adults with moderate to severe COPD who are not adequately treated by a combination of inhaled corticosteroids and long-acting beta-agonist (LABA), or LABA and long-acting muscarinic-antagonist
Locations (7)
Research Site
Mississauga, Canada
Research Site
Hamburg, Germany
Research Site
Athens, Greece
Research Site
Milan, Italy
Research Site
Tokyo, Japan
Research Site
Bucharest, Romania
Research Site
London, United Kingdom